These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 19049747)

  • 1. Invited commentary.
    Anselmi A; De Cecco CN
    Ann Thorac Surg; 2008 Nov; 86(5):1553. PubMed ID: 19049747
    [No Abstract]   [Full Text] [Related]  

  • 2. Myocardial viability mapping by magnetic resonance-based multiparametric systolic strain analysis.
    Cupps BP; Bree DR; Wollmuth JR; Howells AC; Voeller RK; Rogers JG; Pasque MK
    Ann Thorac Surg; 2008 Nov; 86(5):1546-53. PubMed ID: 19049746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial viability: evidence provided by the analysis of left ventricular systolic function.
    Lucas JR; Botvinick EH; Dae MW
    Coron Artery Dis; 1993 Jun; 4(6):485-94. PubMed ID: 8261226
    [No Abstract]   [Full Text] [Related]  

  • 4. Automated detection of regional wall motion abnormalities based on a statistical model applied to multislice short-axis cardiac MR images.
    Suinesiaputra A; Frangi AF; Kaandorp TA; Lamb HJ; Bax JJ; Reiber JH; Lelieveldt BP
    IEEE Trans Med Imaging; 2009 Apr; 28(4):595-607. PubMed ID: 19211347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiac magnetic resonance spectroscopy and chemical shift imaging].
    Mitsunami K; Nakae I; Yabe T; Inubushi T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():305-10. PubMed ID: 12734989
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics and mechanisms of inotropic function disorders in myocardial biopsy specimens in ischemic heart disease].
    Afanas'ev SA; Lebedev AV; Cherniavskiĭ AM; Alekseeva ED; Makarova MN; Naumova AV; Pekarskiĭ VV; Karpov RS
    Fiziol Cheloveka; 1996; 22(4):91-5. PubMed ID: 8964313
    [No Abstract]   [Full Text] [Related]  

  • 7. Images in cardiovascular medicine. Lipomatous metaplasia in ischemic cardiomyopathy: a common but unappreciated entity.
    Schmitt M; Samani N; McCann G
    Circulation; 2007 Jul; 116(1):e5-6. PubMed ID: 17606850
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adaptive changes in the myocardium of patients with ischemic heart disease].
    Afanas'ev SA; Pavliukova EN; Akhmedov ShD; Karpov RS
    Fiziol Cheloveka; 2006; 32(2):61-6. PubMed ID: 16669222
    [No Abstract]   [Full Text] [Related]  

  • 9. Invited commentary.
    Rosenkranz ER
    Ann Thorac Surg; 2007 Sep; 84(3):863. PubMed ID: 17720391
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of myocardial viability: review of the clinical significance.
    Ramos M; DePasquale E; Coplan NL
    Rev Cardiovasc Med; 2008; 9(4):225-31. PubMed ID: 19122580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.
    Takeda K; Matsumiya G; Matsue H; Hamada S; Sakaki M; Sakaguchi T; Fujita T; Sawa Y
    J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1514-21. PubMed ID: 19114200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why is the surgical ventricular restoration operation effective for ischemic cardiomyopathy? Geometric analysis with magnetic resonance imaging of changes in regional ventricular function after surgical ventricular restoration.
    Yu HY; Chen YS; Tseng WY; Chi NS; Wang CH; Wang SS; Lin FY
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):887-94. PubMed ID: 19327513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial viability and revascularization.
    Kanderian AS; Renapurkar R; Flamm SD
    Heart Fail Clin; 2009 Jul; 5(3):333-48, vi. PubMed ID: 19564012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiant diagnostics without radiation].
    Carlsson M; Arheden H
    Lakartidningen; 2008 Oct 22-28; 105(43):3033-7. PubMed ID: 19024618
    [No Abstract]   [Full Text] [Related]  

  • 15. Area at risk and viability after myocardial ischemia and reperfusion can be determined by contrast-enhanced cardiac magnetic resonance imaging.
    Vosseler M; Abegunewardene N; Hoffmann N; Petersen SE; Becker D; Cleppien D; Kunz P; Kreitner KF; Lauterbach M; Bierbach B; Düber C; Gori T; Munzel T; Schreiber LM; Horstick G
    Eur Surg Res; 2009; 43(1):13-23. PubMed ID: 19365131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of echocardiographic two-dimensional speckle tracking longitudinal strain imaging for viability assessment in patients with chronic ischemic left ventricular dysfunction and comparison with contrast-enhanced magnetic resonance imaging.
    Roes SD; Mollema SA; Lamb HJ; van der Wall EE; de Roos A; Bax JJ
    Am J Cardiol; 2009 Aug; 104(3):312-7. PubMed ID: 19616660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical model for predicting mechanotransduction effects in engineered cardiac tissue.
    Latimer DC; Roth BJ; Parker KK
    Tissue Eng; 2003 Apr; 9(2):283-9. PubMed ID: 12740090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A computationally efficient method for determining the size and location of myocardial ischemia.
    Ruud TS; Nielsen BF; Lysaker M; Sundnes J
    IEEE Trans Biomed Eng; 2009 Feb; 56(2):263-72. PubMed ID: 19342326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospects of physical stress testing ].
    Simonova ON; Roze EN
    Fiziol Cheloveka; 2003; 29(4):124-8. PubMed ID: 13677208
    [No Abstract]   [Full Text] [Related]  

  • 20. Delayed enhancement morphology on cardiac magnetic resonance imaging is correlated with signal-averaged electrocardiogram and QT dispersion in myocardial infarction.
    Takase B; Nagata M
    Angiology; 2009; 60(4):412-8. PubMed ID: 19124453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.